N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer.

Authors:
Nie X; Tan J.

Journal:
Hereditas

Publication Year: 2022

DOI:
10.1186/s41065-022-00222-3

PMCID:
PMC8933961

PMID:
35303965

Journal Information

Full Title: Hereditas

Abbreviation: Hereditas

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot acceptable. Consent for publicationNot acceptable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This work was supported by the the Major Special Construction Plan for Discipline Construction Project of China Medical University (3110118033) and the Outstanding Scientific Fund of Shengjing Hospital of China Medical University."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025